The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Produodopa 240 mg/ml + 12 mg/ml solution for infusion



AbbVie LimitedPA1824/002/003

Main Information

Trade NameProduodopa 240 mg/ml + 12 mg/ml solution for infusion
Active SubstancesFoslevodopa
Foscarbidopa
Dosage FormSolution for infusion
Licence HolderAbbVie Limited
Licence NumberPA1824/002/003

Group Information

ATC CodeN04BA Dopa and dopa derivatives

Status

License statusAuthorised
Licence Issued23/09/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - Patient

« Back